Development and evaluation of a trehalose-contained solution formula to preserve hUC-MSCs at 4°C

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 879-884

  Di, Guohu ^a   Wang, Jiexi ^b   Liu, Minxia ^b   Wu, Chu Tse ^a,c   Han, Ying ^b   Duan, Haifeng ^c  

^a TIANJIN UNIVERSITY   (China)

^b BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE ANTIGEN; TREHALOSE;

ARTICLE; BLOOD STORAGE; CELL GROWTH; CELL SURVIVAL; CELL TRANSPORT; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN CELL; KINETICS; MESENCHYMAL STEM CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UMBILICAL CORD BLOOD;

APOPTOSIS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; COLD TEMPERATURE; CRYOPRESERVATION; HUMANS; MESENCHYMAL STEM CELLS; ORGAN PRESERVATION SOLUTIONS; TREHALOSE;

EID: 84155192360     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.23066     Document Type: Article

References (31)

1. Alessandrino P, Bernasconi P, Caldera D, Colombo A, Bonfichi M, Malcovati L, Klersy C, Martinelli G, Maiocchi M, Pagnucco G, Varettoni M, Perotti C, Bernasconi C. 1999. Adverse events occurring during bone marrow or peripheral blood progenitor cell infusion: Analysis of 126 cases. Bone Marrow Transplant 23: 533-537.
2. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T. 2007. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 46: 219-228.
3. Bosse R, Singhofer-Wowra M, Rosenthal F, Schulz G. 1997. Good manufacturing practice production of human stem cells for somatic cell and gene therapy. Stem Cells 15: 275-280.
4. Chen T, Acker JP, Eroglu A, Cheley S, Bayley H, Fowler A, Toner M. 2001. Beneficial effect of intracellular trehalose on the membrane integrity of dried mammalian cells. Cryobiology 43: 168-181.
5. Crowe JH, Tablin F, Wolkers WF, Gousset K, Tsvetkova NM, Ricker J. 2003. Stabilization of membranes in human platelets freeze-dried with trehalose. Chem Phys Lipids 122: 41-52.
6. de Boer F, Drager AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, van der Lelie J, Huijgens PC, Ossenkoppele GJ, Schuurhuis GJ. 2002. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 29: 249-255.
7. Erdag G, Eroglu A, Morgan J, Toner M. 2002. Cryopreservation of fetal skin is improved by extracellular trehalose. Cryobiology 44: 218-228.
8. Eroglu A, Russo MJ, Bieganski R, Fowler A, Cheley S, Bayley H, Toner M. 2000. Intracellular trehalose improves the survival of cryopreserved mammalian cells. Nat Biotechnol 18: 163-167.
9. Eroglu A, Toner M, Toth TL. 2002. Beneficial effect of microinjected trehalose on the cryosurvival of human oocytes. Fertil Steril 77: 152-158.
10. Fuller BJ. 2004. Cryoprotectants: The essential antifreezes to protect life in the frozen state. Cryo Letters 25: 375-388.
11. Hou L, Cao H, Wang D, Wei G, Bai C, Zhang Y, Pei X. 2003. Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro. Int J Hematol 78: 256-261.
12. Junior AM, Arrais CA, Saboya R, Velasques RD, Junqueira PL, Dulley FL. 2008. Neurotoxicity associated with dimethylsulfoxide-preserved hematopoietic progenitor cell infusion. Bone Marrow Transplant 41: 95-96.
13. Katenz E, Vondran FW, Schwartlander R, Pless G, Gong X, Cheng X, Neuhaus P, Sauer IM. 2007. Cryopreservation of primary human hepatocytes: The benefit of trehalose as an additional cryoprotective agent. Liver Transpl 13: 38-45.
14. Lange C, Cakiroglu F, Spiess AN, Cappallo-Obermann H, Dierlamm J, Zander AR. 2007. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol 213: 18-26.
15. Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, Han ZB, Xu ZS, Lu YX, Liu D, Chen ZZ, Han ZC. 2006. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91: 1017-1026.
16. Muraki K, Hirose M, Kotobuki N, Kato Y, Machida H, Takakura Y, Ohgushi H. 2006. Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation. Tissue Eng 12: 1711-1719.
17. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. 2004. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab Investig 84: 607-617.
18. Pal R, Hanwate M, Totey SM. 2008. Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J Tissue Eng Regen Med 2: 436-444.
19. Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J, Moorman M, Simonetti D, Craig S, Marshak D. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143.
20. Pu LL, Cui X, Fink BF, Cibull ML, Gao D. 2005. Cryopreservation of adipose tissues: The role of trehalose. Aesthet Surg J 25: 126-131.
21. Richards AB, Krakowka S, Dexter LB, Schmid H, Wolterbeek AP, Waalkens-Berendsen DH, Shigoyuki A, Kurimoto M. 2002. Trehalose: A review of properties, history of use and human tolerance, and results of multiple safety studies. Food Chem Toxicol 40: 871-898.
22. Rodrigues JP, Paraguassu-Braga FH, Carvalho L, Abdelhay E, Bouzas LF, Porto LC. 2008. Evaluation of trehalose and sucrose as cryoprotectants for hematopoietic stem cells of umbilical cord blood. Cryobiology 56: 144-151.
23. Salem HK, Thiemermann C. 2010. Mesenchymal stromal cells: Current understanding and clinical status. Stem Cells 28: 585-596.
24. Satpathy GR, Torok Z, Bali R, Dwyre DM, Little E, Walker NJ, Tablin F, Crowe JH, Tsvetkova NM. 2004. Loading red blood cells with trehalose: A step towards biostabilization. Cryobiology 49: 123-136.
25. Seo JM, Sohn MY, Suh JS, Atala A, Yoo JJ, Shon YH. 2011. Cryopreservation of amniotic fluid-derived stem cells using natural cryoprotectants and low concentrations of dimethylsulfoxide. Cryobiology 62: 167-173.
26. Stacey GN, Masters JR. 2008. Cryopreservation and banking of mammalian cell lines. Nat Protoc 3: 1981-1989
27. Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M. 2004. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 96: 1593-1603.
28. Thirumala S, Goebel WS, Woods EJ. 2009. Clinical grade adult stem cell banking. Organogenesis 5: 143-154.
29. Umemura E, Yamada Y, Nakamura S, Ito K, Hara K, Ueda M. 2011. Viable cryopreserving tissue-engineered cell-biomaterial for cell banking therapy in an effective cryoprotectant. Tissue Eng Part C Methods 17: 799-807.
30. Wang HY, Lun ZR, Lu SS. 2011. Cryopreservation of umbilical cord blood-derived mesenchymal stem cells without dimethyl sulfoxide. Cryo Letters 32: 81-88.
31. Zambelli A, Poggi G, Da Prada G, Pedrazzoli P, Cuomo A, Miotti D, Perotti C, Preti P, Robustelli della, Cuna G. 1998. Clinical toxicity of cryopreserved circulating progenitor cells infusion. Anticancer Res 18: 4705-4708.